AGE

AgeX Therapeutics, Inc.

0.39 USD
+0.02 (+5.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

AgeX Therapeutics, Inc. stock is down -4.88% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 February’s closed higher than January.

About AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity.